Regenerative medicine company LifeNet Health revealed on Wednesday that it has completed the first of three phases of its state-of-the-art Virginia Beach processing facility, which strengthens its operational and logistical capabilities.
Under the first phase of the project, the company has consolidated the logistics associated with providing technologically advanced bone grafts as well as cardiac and vascular grafts, which are used to repair life-threatening heart and circulatory system defects.
A supporting facility since 2001, the investment in the company's satellite location on Bayside Road, near Norfolk International Airport, will make it the largest of the four tissue graft-processing facilities once all phases are complete. In total, it represents half of the more than USD12m dedicated to facilities in Virginia since 2017.
In addition, the company has hired more than 200 people for highly skilled, technical jobs in Virginia under the phase one of the project.
By April 2021, the Bayside facility will include 20 Class 10,000 clean rooms, specialised suites designed to ensure the safety of the grafts as well as to prepare and store critically needed tissues.
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients
AbbVie announces interim evaluation of Atogepant Phase three, open-label 156-week extension study
Precision Epigenomics partners with TruDiagnostic
Modalis partners with Ginkgo Bioworks
Stamford Pharmaceuticals starts locally advanced basal cell carcinoma (laBCC) trial of SP-002
Algiax Pharmaceuticals reveals update on chronic neuropathic pain study